Costs (€), mean (95% CI) | QoL (15D), mean (95% CI) | ICER (€/QALY) | |||||
---|---|---|---|---|---|---|---|
Intervention | Control | Incremental cost | Intervention | Control | Incremental effect | ||
Type 2 diabetes | 1948 (1673–2222) | 1788 (1204–2371) | 160 (−406–726) | 0.008 (0.003– 0.014) | 0.000 (−0.009–0.009) | 0.008 (−0.002–0.018) | 20 000 |
Coronary artery disease | 2510 (1806–3214) | 1785 (984–2585) | 725 (−389–1839) | 0.019 (0.007–0.030) | 0.001 (−0.014–0.016) | 0.018 (−0.001–0.037) | 40 278 |
Congestive heart failure | 4469 (1955–6983) | 2214 (−105–4533) | 2255 (−1669–6180) | 0.013 (−0.007–0.032) | 0.015 (−0.015–0.046) | −0.003 (−0.037–0.032 | - |
All | 2256 (1940–2571) | 1824 (1345–2302) | 432 (−135–999) | 0.011 (0.006 − 0.015) | 0.002 (−0.006–0.009) | 0.009 (0.000–0.018) | 48 000 |